Online CPR Certification Blog
High levels of cholesterol are linked with less chance of having colon cancer
Date: June 15th, 2016
Statins and colon cancer relation
In a news interview, it has been revealed that with the long-term use of cholesterol lowering statins can help in lessening the risk of colon cancer, but this is not true. In the said interview, it has been said that the statins will not help in lessening the odds of colon cancer, however, the person’s cholesterol levels may affect the odds, and this is in accordance to the newest study. Over 22 thousand patients with colon cancer have statins and high cholesterol levels and over 86 thousand people without the said disease. The outcomes have been known in relation with the findings that showed a lower risk of colon cancer among those who took statins for years. However, the risk wasn’t important at all, between those who just kept in taking the pill and those who have just stopped taking it.
Whereas, the higher the cholesterol levels, the lower the colon cancer odds for the people, this is regardless of the statin use, in accordance with the study. The researchers have found out as well that there is a hard to elaborate decrease in the cholesterol levels a year before the cancer detection went on and was associated with a rise in the odds of having cancer in both statin and non-statin users. However, the study wasn’t able to provide a proof that the lower the cholesterol levels are, the lesser risk of having colon cancer or the higher the risk will be, it just showed a link between the 2.
What the diagnosis has to say
According to the diagnosis that has been posited on the 26th of April this year, 2016 in a medicine journal, they bid that cholesterol levels and statins might both affect the odds of a patient in having colon cancer. It shows to be a hollowly secure effect of the statins. This is in accordance with the research made by a doctor in a University in Philadelphia. He is also a professor in hematology and in oncology. Even if the risk of colon cancer is quite low among users of statin vs. the non-users when compared to those who went on with the cancer statin therapy vs. those who went on with the treatment, with this in every group shared some indication for the statin use, there has been no proof of the risk said the professor.
Along with the data shows some complex linked with the statins, colon cancer and cholesterol as well, he added. Though there is a hard to elaborate rise in the blood cholesterol count that may give a heightened attention to the doctors to consider colon cancer as among the possible topics that must be discussed for the studies in the next years to come, they must still confirm the link between the blood cholesterol as a marker for the early sign and diagnosis of colon cancer.